591 related articles for article (PubMed ID: 9864924)
21. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Marcucci G; Mrózek K; Ruppert AS; Maharry K; Kolitz JE; Moore JO; Mayer RJ; Pettenati MJ; Powell BL; Edwards CG; Sterling LJ; Vardiman JW; Schiffer CA; Carroll AJ; Larson RA; Bloomfield CD
J Clin Oncol; 2005 Aug; 23(24):5705-17. PubMed ID: 16110030
[TBL] [Abstract][Full Text] [Related]
22. The treatment of adult acute myeloid leukemia.
Bishop JF
Semin Oncol; 1997 Feb; 24(1):57-69. PubMed ID: 9045305
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.
Ferrara F; Del Vecchio L
Haematologica; 2002 Mar; 87(3):306-19. PubMed ID: 11869944
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloid leukemia].
Miyazaki Y; Kuriyama K
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1192-8. PubMed ID: 11579629
[TBL] [Abstract][Full Text] [Related]
26. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
27. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
28. Maintenance therapy in childhood acute myeloid leukemia.
Perel Y; Auvrignon A; Leblanc T; Michel G; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Mèchinaud F; Lamagnere JP; Piguet Ch; Couillaud G; Pautard B; Baruchel A; Leverger G; ;
Ann Hematol; 2004; 83 Suppl 1():S116-9. PubMed ID: 15124700
[TBL] [Abstract][Full Text] [Related]
29. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.
Lo-Coco F; Cuneo A; Pane F; Cilloni D; Diverio D; Mancini M; Testoni N; Bardi A; Izzo B; Bolli N; La Starza R; Fazi P; Iacobelli S; Piciocchi A; Vignetti M; Amadori S; Mandelli F; Pelicci PG; Mecucci C; Falini B; Saglio G;
Haematologica; 2008 Jul; 93(7):1017-24. PubMed ID: 18508799
[TBL] [Abstract][Full Text] [Related]
32. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
33. Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
Ferrara F; Morabito F; Latagliata R; Martino B; Annunziata M; Oliva E; Schiavone EM; Pollio F; Palmieri S; Gianfaldoni G; Leoni F
Haematologica; 2001 Aug; 86(8):814-20. PubMed ID: 11522537
[TBL] [Abstract][Full Text] [Related]
34. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
Poppe B; De Paepe A; Speleman F
Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
[TBL] [Abstract][Full Text] [Related]
35. De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Northern Region Haematology Group.
Taylor PR; Reid MM; Stark AN; Bown N; Hamilton PJ; Proctor SJ
Leukemia; 1995 Feb; 9(2):231-7. PubMed ID: 7532766
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
37. Adult acute leukemia.
Cripe LD
Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
[TBL] [Abstract][Full Text] [Related]
38. More individual markers are necessary for patients with acute myeloid leukemia (AML). Does cytomorphology or cytogenetics define the biological entity?
Haferlach T
Leukemia; 1996 Jul; 10 Suppl 3():S5-S9. PubMed ID: 8656701
[TBL] [Abstract][Full Text] [Related]
39. New insights in the management of elderly patients with acute myeloid leukemia.
Dombret H; Raffoux E; Gardin C
Curr Opin Oncol; 2009 Nov; 21(6):589-93. PubMed ID: 19812493
[TBL] [Abstract][Full Text] [Related]
40. The approach to the elderly patient with acute myeloid leukemia.
Stone RM; Mayer RJ
Hematol Oncol Clin North Am; 1993 Feb; 7(1):65-79. PubMed ID: 7680642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
